Magnus Rasmussen
31 – 40 of 156
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Risk stratification score screening for infective endocarditis in patients with Gram-positive bacteraemia
(
- Contribution to journal › Article
-
Mark
Surveillance of COVID-19 vaccine effectiveness : A real-time case-control study in southern Sweden
(
- Contribution to journal › Article
-
Mark
Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022
2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(9).(
- Contribution to journal › Article
-
Mark
COVID-19 vaccine effectiveness against severe disease from the Omicron BA.1 and BA.2 subvariants: surveillance results from southern Sweden, December 2021 to March 2022
2022)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
(
- Contribution to journal › Article
-
Mark
True infection or contamination in patients with positive Cutibacterium blood cultures-a retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Enterococcus faecalis bacteremia, cardiac implantable electronic device, extraction, and the risk of recurrence
(
- Contribution to journal › Article
-
Mark
Treatment Strategies and Risk of Recurrence in Patients with Heart Valve Prosthesis, Staphylococcus aureus Bacteremia, and Possible Endocarditis - A Retrospective Cohort Study
(
- Contribution to journal › Article
-
Mark
Get the Species Right : Aerococcus viridans is Likely not Responsible
(
- Contribution to journal › Letter
-
Mark
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
(
- Contribution to journal › Article